• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不是一种典型的呼吸道病原体。

: not a typical respiratory pathogen.

机构信息

Microbiology and Infection Research Group, Department of Biomedical Sciences, Cardiff Metropolitan University, Western Avenue, Cardiff. CF5 2YB, UK.

Division of Infectious Diseases and Hospital Epidemiology, Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.

出版信息

J Med Microbiol. 2024 Oct;73(10). doi: 10.1099/jmm.0.001910.

DOI:10.1099/jmm.0.001910
PMID:39475213
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11523975/
Abstract

is a leading cause of community-acquired pneumonia among school-aged children and young adults. Infections occur throughout the year but tend to surge during winter months across Europe. A characteristic epidemic cycle, where a substantial surge in the number of infections occurs, is seen approximately every 1-4 years and hypothesized to be driven by changes in immunity and a shift in circulating variants. Once thought to be an organism of low virulence, it has now been found to possess several virulence factors, including toxin production, biofilm formation and evasion of antibody-mediated immunity. The lack of a cell wall and reduced metabolic pathways limit the options for antibiotic treatment. Acquired macrolide resistance is a growing concern, with >80% of cases in China being macrolide-resistant. Although efforts have been made to develop a vaccine, there are still substantial hurdles to overcome in relation to vaccine-enhanced disease, which results from an inappropriate immune response among vaccinated individuals.

摘要

是导致学龄儿童和青年社区获得性肺炎的主要原因之一。感染全年都有发生,但在欧洲的冬季月份往往会激增。大约每 1-4 年就会出现一个特征性的流行周期,大量感染病例会突然增加,这被认为是由免疫变化和循环变异引起的。过去被认为是一种低毒力的病原体,现在已经发现它具有多种毒力因子,包括毒素产生、生物膜形成和逃避抗体介导的免疫。缺乏细胞壁和减少的代谢途径限制了抗生素治疗的选择。获得性大环内酯类耐药性是一个日益令人关注的问题,在中国,超过 80%的病例对大环内酯类耐药。尽管已经做出努力来开发疫苗,但在与疫苗增强疾病相关的方面仍然存在很大的障碍,疫苗增强疾病是由于接种人群中产生了不适当的免疫反应。

相似文献

1
: not a typical respiratory pathogen.不是一种典型的呼吸道病原体。
J Med Microbiol. 2024 Oct;73(10). doi: 10.1099/jmm.0.001910.
2
Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.多西环素治疗儿童大环内酯类耐药肺炎支原体相关社区获得性肺炎后的快速退热
Pediatr Infect Dis J. 2013 Dec;32(12):1396-9. doi: 10.1097/INF.0b013e3182a25c71.
3
Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.6 岁男孩患耐大环内酯类肺炎支原体所致重症社区获得性肺炎。
Hong Kong Med J. 2011 Oct;17(5):407-9.
4
[Macrolide-resistant Mycoplasma pneumoniae: Do we know the situation in Europe?].[耐大环内酯类肺炎支原体:我们了解欧洲的情况吗?]
Rev Esp Quimioter. 2023 Jun;36(3):259-266. doi: 10.37201/req/118.2022. Epub 2023 Mar 27.
5
A study of community-acquired in Yantai, China.中国烟台一项关于社区获得性(疾病)的研究。 (原句表述不完整,推测补充完整后大致是这样的意思,因为“A study of community-acquired...”后面缺少具体所研究的关于社区获得性的内容,比如疾病等)
Colomb Med (Cali). 2018 Jun 30;49(2):160-163. doi: 10.25100/cm.v49i2.3813.
6
Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.肺炎支原体肺炎抗菌治疗选择概述:关注大环内酯类耐药性
Clin Respir J. 2017 Jul;11(4):419-429. doi: 10.1111/crj.12379. Epub 2015 Oct 13.
7
Current Mycoplasma pneumoniae outbreak: Don't forget its role in Bickerstaff encephalitis.当前肺炎支原体爆发:别忘记其在 Bickerstaff 脑炎中的作用。
Diagn Microbiol Infect Dis. 2024 Sep;110(1):116418. doi: 10.1016/j.diagmicrobio.2024.116418. Epub 2024 Jun 28.
8
First Description of Macrolide-Resistant in Adults with Community-Acquired Pneumonia in Italy.意大利成人社区获得性肺炎中大环内酯类耐药的首次描述。
Biomed Res Int. 2019 Mar 17;2019:7168949. doi: 10.1155/2019/7168949. eCollection 2019.
9
Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.大环内酯类耐药肺炎支原体:分离株的特征和社区获得性肺炎的临床方面。
J Infect Chemother. 2010 Apr;16(2):78-86. doi: 10.1007/s10156-009-0021-4. Epub 2010 Jan 22.
10
Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.成人社区获得性肺炎中对大环内酯类耐药的肺炎支原体
Int J Antimicrob Agents. 2010 Oct;36(4):384-5. doi: 10.1016/j.ijantimicag.2010.06.009. Epub 2010 Jul 31.

引用本文的文献

1
Adult Hospitalized Mycoplasma Cases in a Tertiary Hospital in Japan.日本一家三级医院的成人住院支原体病例
Infect Drug Resist. 2025 Aug 15;18:4119-4124. doi: 10.2147/IDR.S541327. eCollection 2025.
2
Assessment of serum parameters caused by the outbreak of mycoplasma pneumoniae pneumonia in children after COVID-19.新冠疫情后儿童支原体肺炎爆发所致血清参数评估
Sci Rep. 2025 Aug 3;15(1):28306. doi: 10.1038/s41598-025-13555-6.
3
Implementation of a Laboratory-Developed Test for the Diagnosis of Using a High-Throughput Approach.采用高通量方法实施用于诊断的实验室自建检测方法。
Pathogens. 2025 Jul 14;14(7):692. doi: 10.3390/pathogens14070692.

本文引用的文献

1
Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.儿童肺炎支原体肺炎治疗面临的挑战。
Eur J Pediatr. 2024 Jul;183(7):3001-3011. doi: 10.1007/s00431-024-05519-1. Epub 2024 Apr 18.
2
Increased incidence of infections and hospital admissions in the Netherlands, November to December 2023.2023年11月至12月荷兰感染率和住院率上升。
Euro Surveill. 2024 Jan;29(4). doi: 10.2807/1560-7917.ES.2024.29.4.2300724.
3
Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China.中国大环内酯类耐药流行克隆株导致支原体肺炎的再现。
Lancet Microbe. 2024 Jun;5(6):e515. doi: 10.1016/S2666-5247(23)00405-6. Epub 2024 Jan 17.
4
epidemic in Denmark, October to December, 2023.2023 年 10 月至 12 月丹麦的疫情。
Euro Surveill. 2024 Jan;29(2). doi: 10.2807/1560-7917.ES.2024.29.2.2300707.
5
Childhood community-acquired pneumonia.儿童社区获得性肺炎。
Eur J Pediatr. 2024 Mar;183(3):1129-1136. doi: 10.1007/s00431-023-05366-6. Epub 2023 Dec 19.
6
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions.肺炎支原体:在新冠疫情限制措施后延迟再现。
Lancet Microbe. 2024 Feb;5(2):e100-e101. doi: 10.1016/S2666-5247(23)00344-0. Epub 2023 Nov 23.
7
Genotyping of strains isolated in Japan during 2019 and 2020: spread of gene type 2c and 2j variant strains.2019年至2020年期间在日本分离出的菌株的基因分型:2c型和2j变异株的传播
Front Microbiol. 2023 Jun 19;14:1202357. doi: 10.3389/fmicb.2023.1202357. eCollection 2023.
8
Mycoplasma pneumoniae: gone forever?肺炎支原体:一去不复返了?
Lancet Microbe. 2023 Oct;4(10):e763. doi: 10.1016/S2666-5247(23)00182-9. Epub 2023 Jun 29.
9
B cells oppose Mycoplasma pneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs.B细胞对抗肺炎支原体疫苗增强疾病,并限制肺部细菌定植。
NPJ Vaccines. 2022 Oct 31;7(1):130. doi: 10.1038/s41541-022-00556-z.
10
Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?新冠疫情之后的肺炎支原体:它在哪里?
Lancet Microbe. 2022 Dec;3(12):e897. doi: 10.1016/S2666-5247(22)00190-2. Epub 2022 Aug 11.